NBIX
Neurocrine Biosciences Inc
NASDAQ: NBIX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$131.23
+2.43% today
Updated 2026-04-29
Market cap
$13.20B
P/E ratio
28.10
P/S ratio
4.61x
EPS (TTM)
$4.67
Dividend yield
—
52W range
$108 – $160
Volume
1.1M
Neurocrine Biosciences Inc (NBIX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-99.33M | $-59.33M | $-74.17M | $-53.09M | $49.94M | $-698000.00 | $-35.29M | $-29.61M | $-47.14M | $-38.00M | $-106.18M | $-94.33M | $101.40M | $147.00M | $228.50M | $256.50M | $339.40M | $389.90M | $595.40M | $782.70M |
| Capital expenditures | $3.11M | $624000.00 | $1.32M | $35000.00 | $315000.00 | $750000.00 | $971000.00 | $545000.00 | $1.61M | $1.93M | $4.11M | $6.94M | $24.80M | $14.70M | $10.90M | $23.40M | $16.50M | $28.30M | $38.20M | $34.00M |
| Depreciation | $10.57M | $9.40M | $7.61M | $3.18M | $1.44M | $694000.00 | $657000.00 | $671000.00 | $827000.00 | $1.01M | $1.45M | $2.40M | $4.00M | $7.40M | $8.60M | $10.90M | $15.60M | $21.30M | $27.10M | $30.10M |
| Stock-based comp | $14.37M | $9.98M | $7.99M | $5.54M | $3.13M | $2.92M | $5.48M | $6.82M | $10.38M | $28.39M | $28.46M | $42.52M | $58.10M | $75.30M | $100.00M | $134.20M | $173.10M | $194.30M | $195.50M | $217.90M |
| Free cash flow | $-102.44M | $-59.96M | $-75.49M | $-53.13M | $49.63M | $-1.45M | $-36.27M | $-30.15M | $-48.75M | $-39.93M | $-110.29M | $-101.27M | $76.60M | $132.30M | $217.60M | $233.10M | $322.90M | $361.60M | $557.20M | $748.70M |
| Investing cash flow | $120.28M | $20.84M | $44.42M | $12.06M | $-54.70M | $-3.53M | $-34.76M | $5.34M | $-105.37M | $-195.81M | $112.95M | $-251.25M | $-242.90M | $-211.10M | $4.10M | $-130.20M | $-177.10M | $-467.10M | $-126.80M | $-264.40M |
| Financing cash flow | $10.09M | $57.18M | $-1.45M | $9.90M | $21.48M | $286000.00 | $83.70M | $5.30M | $138.73M | $276.99M | $2.39M | $516.65M | $29.50M | $32.40M | $-157.80M | $27.40M | $-234.30M | $65.30M | $-486.70M | $-38.30M |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-3.94M | $13.65M | $-18.96M | $-13.78M | $43.18M | $9.07M | $171.44M | $-112.02M | $-31.71M | $74.80M | $153.70M | $-72.00M | — | — | — |